Immix Biopharma, Inc. in Los Angeles, CA, seeks a Senior CMC Technical Writer (Contract) to author and edit Module 3 and QOS for the first BLA for NXC-201. You will translate source data into regulatory content and coordinate with SMEs and CDMOs to meet filing timelines.
Requirements include CAR-T/CMC cell therapy experience, direct Module 3 authoring for a submitted FDA BLA, and a life sciences or engineering degree. 6-month contract, hybrid or remote, with $100–$150/hr.
#J-18808-Ljbffr
This role, Senior CMC Writer – Cell Therapy & BLA (Contract, Remote) at Immix Biopharma, Inc., could be your next move.
This opportunity is part of our work in Bio & Pharmacology & Health, Engineering.
The advertised compensation is 138.000 - 207.000.
We aim to respond to suitable candidates as soon as possible.
Full responsibilities and requirements are described in the listing above.